Arcus Biosciences, Inc. (RCUS)

USD 7.85

(-0.13%)

Revenue Summary of Arcus Biosciences, Inc.

Arcus Biosciences, Inc.'s latest annual revenue in 2023 was 117 Million USD , up 4.46% from previous year.
Arcus Biosciences, Inc.'s latest quarterly revenue in 2024 Q2 was 39 Million USD , down -73.1% from previous quarter.
Arcus Biosciences, Inc. reported a annual revenue of 112 Million USD in annual revenue 2022, down -70.75% from previous year.
Arcus Biosciences, Inc. reported a annual revenue of 382.88 Million USD in annual revenue 2021, up 393.93% from previous year.
Arcus Biosciences, Inc. reported a quarterly revenue of 145 Million USD for 2024 Q1, up 367.74% from previous quarter.
Arcus Biosciences, Inc. reported a quarterly revenue of 29 Million USD for 2023 Q2, up 16.0% from previous quarter.

Annual Revenue Chart of Arcus Biosciences, Inc. (2023 - 2016)

Historical Annual Revenue of Arcus Biosciences, Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	117 Million USD	4.46%
2022	112 Million USD	-70.75%
2021	382.88 Million USD	393.93%
2020	77.51 Million USD	416.78%
2019	15 Million USD	79.58%
2018	8.35 Million USD	491.15%
2017	1.41 Million USD	0.0%
2016	- USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	39 Million USD	-73.1%
2024 Q1	145 Million USD	367.74%
2023 Q2	29 Million USD	16.0%
2023 FY	117 Million USD	4.46%
2023 Q1	25 Million USD	7146.38%
2023 Q3	32 Million USD	10.34%
2023 Q4	31 Million USD	-3.13%
2022 Q2	26.75 Million USD	48.62%
2022 Q4	345 Thousand USD	-98.97%
2022 FY	112 Million USD	-70.75%
2022 Q1	18 Million USD	-94.92%
2022 Q3	33.58 Million USD	25.49%
2021 Q1	9.46 Million USD	-0.27%
2021 FY	382.88 Million USD	393.93%
2021 Q2	9.46 Million USD	0.0%
2021 Q4	354.49 Million USD	3646.95%
2021 Q3	9.46 Million USD	0.0%
2020 FY	77.51 Million USD	416.78%
2020 Q1	1.75 Million USD	-82.05%
2020 Q2	1.75 Million USD	0.0%
2020 Q3	64.53 Million USD	3587.43%
2020 Q4	9.48 Million USD	-85.3%
2019 Q4	9.75 Million USD	457.14%
2019 Q3	1.75 Million USD	0.0%
2019 Q2	1.75 Million USD	0.0%
2019 Q1	1.75 Million USD	12.04%
2019 FY	15 Million USD	79.58%
2018 Q3	4.29 Million USD	243.28%
2018 FY	8.35 Million USD	491.15%
2018 Q2	1.25 Million USD	0.0%
2018 Q1	1.25 Million USD	0.0%
2018 Q4	1.56 Million USD	-63.6%
2017 Q1	- USD	0.0%
2017 FY	1.41 Million USD	0.0%
2017 Q4	1.25 Million USD	666.87%
2017 Q3	163 Thousand USD	0.0%
2017 Q2	- USD	0.0%
2016 FY	- USD	0.0%

Peer Revenue Comparison of Arcus Biosciences, Inc.

Name	Revenue	Revenue Difference
ADC Therapeutics SA	69.55 Million USD	-68.205%
Alto Neuroscience, Inc.	- USD	-Infinity%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	- USD	-Infinity%
Ginkgo Bioworks Holdings, Inc.	251.45 Million USD	53.471%
Nuvation Bio Inc.	- USD	-Infinity%
Nuvation Bio Inc.	- USD	-Infinity%
Zymeworks Inc.	76.01 Million USD	-53.923%